BTIG raised the firm’s price target on GeneDx (WGS) to $115 from $95 and keeps a Buy rating on the shares. The shares are up roughly 40% after ...

BTIG analyst David Larsen raised the firm’s price target on Consensus Cloud (CCSI) to $37 from $32 and keeps a Buy rating on the shares. The ...

BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain ...

BTIG highlights Wingstop (WING) as a top pick ahead of earnings, citing strong unit growth, supply chain benefits, & robust ...

BTIG analysts maintained their Buy rating and $12.00 price target for SunCar Tech Group (NASDAQ:SDA), currently valued at $468 million. The firm's stance comes after the company's recent secondary ...

Futures and options on the Cboe Volatility Index, the options-derived measure of expected volatility on the S&P 500, expire on Wednesday. That's often proved to be an "inflection" point for the stock ...

Research analysts at BTIG Research reduced their Q4 2025 earnings estimates for shares of D.R. Horton in a research note issued to investors on Tuesday, January 28th. BTIG Research analyst C.

Oncocyte Corp. (Nasdaq: OCX), a pioneering diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend BTIG’s MedTech, ...

Investing.com -- BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain disruptions that could hamper growth in 2025. The brokerage ...

FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the BTIG Annual ...